Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society.
J Diabetes Sci Technol
; 17(6): 1711-1721, 2023 11.
Article
de En
| MEDLINE
| ID: mdl-37555266
ABSTRACT
Lipohypertrophy is a common skin complication associated with insulin-treated diabetes. The impact of lipohypertrophy as a contributing factor to suboptimal glycemic control, glucose variability, and hypoglycemia is often under-recognized by health care professionals. In a recent Webinar on April 26, 2023, Diabetes Technology Society asked international experts to provide updates on the latest knowledge related to lipohypertrophy for practicing clinicians and educators, researchers, and industries involved in insulin delivery. A recording of the Webinar is freely available on the Diabetes Technology Society Web site (https//www.diabetestechnology.org/).
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Diabète de type 1
/
Hypoglycémie
/
Lipodystrophie
Limites:
Humans
Langue:
En
Journal:
J Diabetes Sci Technol
Sujet du journal:
ENDOCRINOLOGIA
Année:
2023
Type de document:
Article
Pays d'affiliation:
États-Unis d'Amérique